Skip to main content
. 2020 Feb 4;21(4):1771–1778. doi: 10.3892/mmr.2020.10973

Table II.

Clinicopathological variables of patients with Kawasaki disease categorized according to the serum anti-HSP7C antibody expression status.

A, Laboratory variables
Serum anti-HSP7C antibody level

Variable Low (n=20) High (n=30) P-value
Sex (female/male) 9/11 13/17 0.9074
Age (years)a 2.6±2.2 2.4±2.3 0.7165
Neutrophil granulocyte %a 52.5±24.6 52.7±22.9 0.9658
C-reactive protein (mg/l)a 53.0±60.5 57.7±49.8 0.7640
Erythrocyte sedimentation rate (mm/h)a 63.5±31.4 60.2±29.6 0.7118
White blood cell (109/l)a 11.2±4.4 11.0±5.1 0.9037
Red blood cell (1012/l)a 4.7±0.3 3.9±0.3 0.1268
Hemoglobin (g/l)a 107.3±12.8 103.1±7.7 0.2018
Blood platelet (109/l)a 461.6±128.0 355.5±140.8 0.0094

B, Clinical variables
Serum anti-HSP7C antibody level

Variable Low (n=20) High (n=30) P-value

Coronary artery lesions (−/+) 13/7 26/4 0.0700
Fever (−/+) 1/19 0/30 0.2160
Lymph nodes (−/+) 2/18 3/27 >0.9999
Bilateral conjunctival hyperemia (−/+) 1/19 1/29 0.7683
Lips red and chapped (−/+) 2/18 1/29 0.3308
Hard swelling of hands and feet (−/+) 5/15 8/22 0.8953
Torsal polymorphic erythema (−/+) 15/5 13/17 0.0271
a

Data are presented as the mean ± SD. FC, non-KD febrile control; HC, healthy control; high group, ELISA cut-off value >0.267; HSP7C, heat shock cognate 71 kDa protein; KD, Kawasaki disease; low group, ELISA cut-off value ≤0.267.